Osaic Holdings
CSTL icon

Osaic Holdings’s Castle Biosciences CSTL Stock Holding History

Osaic Holdings’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21K Sell
857
-35,547
-98% -$1.16M ﹤0.01% 5823
2025
Q4 		$1.42M Buy
36,404
+35,996
+8,823% +$1.16M ﹤0.01% 2379
2025
Q3 		$9.26K Buy
408
+209
+105% +$4.25K ﹤0.01% 6412
2025
Q2 		$4.01K Sell
199
-3
-1% -$56 ﹤0.01% 6661
2025
Q1 		$4.04K Buy
202
+188
+1,343% +$4.66K ﹤0.01% 6282
2024
Q4 		$373 Sell
14
-5,134
-100% -$156K ﹤0.01% 7077
2024
Q3 		$147K Buy
5,148
+648
+14% +$16.5K ﹤0.01% 3909
2024
Q2 		$98K Sell
4,500
-956
-18% -$21.3K ﹤0.01% 4162
2024
Q1 		$121K Sell
5,456
-2,883
-35% -$62.7K ﹤0.01% 4106
2023
Q4 		$180K Buy
8,339
+1,779
+27% +$31.3K ﹤0.01% 4012
2023
Q3 		$111K Buy
6,560
+2,934
+81% +$51.3K ﹤0.01% 4430
2023
Q2 		$49.7K Buy
3,626
+984
+37% +$19.9K ﹤0.01% 4940
2023
Q1 		$60K Buy
2,642
+178
+7% +$4.35K ﹤0.01% 4828
2022
Q4 		$59K Sell
2,464
-60
-2% -$1.39K ﹤0.01% 4805
2022
Q3 		$65K Buy
2,524
+156
+7% +$4.37K ﹤0.01% 4699
2022
Q2 		$52K Sell
2,368
-3,879
-62% -$90.1K ﹤0.01% 4924
2022
Q1 		$279K Sell
6,247
-998
-14% -$41.2K ﹤0.01% 3741
2021
Q4 		$310K Buy
7,245
+678
+10% +$35.4K ﹤0.01% 3527
2021
Q3 		$437K Buy
6,567
+495
+8% +$34.8K ﹤0.01% 3173
2021
Q2 		$444K Buy
6,072
+3,006
+98% +$199K ﹤0.01% 3147
2021
Q1 		$210K Buy
3,066
+774
+34% +$58.2K ﹤0.01% 3691
2020
Q4 		$154K Buy
2,292
+2,248
+5,109% +$122K ﹤0.01% 3712
2020
Q3 		$2K Buy
44
+42
+2,100% +$1.87K ﹤0.01% 5832
2020
Q2 		$0 Hold
2
– – ﹤0.01% 6143
2020
Q1 		$0 Buy
+2
New +$60 ﹤0.01% 6082

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Osaic Holdings's CSTL Position: Q1 2026 in Review

Osaic Holdings reduced its Castle Biosciences (CSTL) stake by 98% in Q1 2026, selling an estimated $1.16M and leaving 857 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #5823.

Osaic Holdings first reported a position in CSTL in Q1 2020 and has held it in 25 quarters since. The position peaked at $1.42M in Q4 2025. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • Osaic Holdings held 857 shares of Castle Biosciences worth $21K as of Q1 2026.
  • Osaic Holdings sold 35,547 Castle Biosciences shares in Q1 2026, an estimated $1.16M.
  • Castle Biosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5823 holding.
  • Osaic Holdings first reported a position in Castle Biosciences in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Castle Biosciences position peaked at $1.42M in Q4 2025.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.